Sara Pepe | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation	EUROPEAN JOURNAL OF HAEMATOLOGY	2024
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real‐life multicenter Italian cohort	HEMATOLOGICAL ONCOLOGY	2024
Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS	FRONTIERS IN ONCOLOGY	2023
One-month qRT-PCR BCR::ABL1 transcript threshold to predict early recurrence in chronic phase CML patients attempting first treatment free remission	EUROPEAN JOURNAL OF HAEMATOLOGY	2023
Validation of imatinib therapy failure score (IMTF) in chronic phase chronic myeloid leukemia in real life practice	LEUKEMIA & LYMPHOMA	2023
Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort	EUROPEAN JOURNAL OF HAEMATOLOGY	2023
Pre‐exposure prophylaxis with tixagevimab/cilgavimab in patients with chronic lymphocytic leukaemia treated with targeted agents	BRITISH JOURNAL OF HAEMATOLOGY	2023
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study	CANCERS	2023
Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS	FRONTIERS IN ONCOLOGY	2023
Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients	EXPERT REVIEW OF HEMATOLOGY	2022
Future Management of Chronic Myeloid Leukemia: From Dose Optimization to New Agents	CURRENT CANCER DRUG TARGETS	2022
Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group	ANNALS OF HEMATOLOGY	2022
Immunomodulatory Effects of IFNα on T and NK Cells in Chronic Myeloid Leukemia Patients in Deep Molecular Response Preparing for Treatment Discontinuation	JOURNAL OF CLINICAL MEDICINE	2022
Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL)	LEUKEMIA	2021
Long-term follow-up of late chronic phase chronic myeloid leukemia patients treated with imatinib after interferon failure: a single center experience	LEUKEMIA & LYMPHOMA	2021
Therapeutic strategies in low and high-risk MDS: What does the future have to offer?	BLOOD REVIEWS	2021
Real-life evaluation of potential candidates for treatment discontinuation in chronic myeloid leukemia: the impact of age and long-term follow-up	LEUKEMIA & LYMPHOMA	2021
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients	ANNALS OF HEMATOLOGY	2021
Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of 2001 WHO Versus 2008/2016 WHO Criteria in a Large Single-center Cohort	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA	2021
Real-life evaluation of potential candidates for treatment discontinuation in chronic myeloid leukemia: the impact of age and long-term follow-up	LEUKEMIA & LYMPHOMA	2021